MA
PRCT icon

MCF Advisors’s Procept Biorobotics PRCT Stock Holding History

MCF Advisors’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-219
Closed -$12.6K – 993
2025
Q2 		$12.6K Buy
219
+74
+51% +$4.18K ﹤0.01% 615
2025
Q1 		$8.45K Sell
145
-174
-55% -$11.9K ﹤0.01% 680
2024
Q4 		$25.7K Buy
319
+10
+3% +$854 ﹤0.01% 508
2024
Q3 		$24.8K Buy
309
+38
+14% +$2.7K ﹤0.01% 505
2024
Q2 		$16.6K Buy
271
+160
+144% +$9.52K ﹤0.01% 571
2024
Q1 		$5.49K Buy
111
+33
+42% +$1.57K ﹤0.01% 706
2023
Q4 		$3.27K Sell
78
-83
-52% -$2.83K ﹤0.01% 727
2023
Q3 		$5.28K Buy
161
+31
+24% +$1.06K ﹤0.01% 653
2023
Q2 		$4.6K Buy
130
+61
+88% +$2.02K ﹤0.01% 642
2023
Q1 		$1.96K Buy
+69
New +$2.43K ﹤0.01% 710

Other funds holding PRCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

MCF Advisors's PRCT Position: Q3 2025 in Review

MCF Advisors sold out of Procept Biorobotics (PRCT) in Q3 2025, closing a stake of 219 shares — an estimated $12.6K sold.

MCF Advisors first reported a position in PRCT in Q1 2023 and held it in 10 quarters. The position peaked at $25.7K in Q4 2024. 242 funds tracked by Wall St. Rank hold PRCT as of Q3 2025.

  • MCF Advisors reported no remaining Procept Biorobotics position as of Q3 2025 after selling out during the quarter.
  • MCF Advisors sold 219 Procept Biorobotics shares in Q3 2025, an estimated $12.6K.
  • MCF Advisors first reported a position in Procept Biorobotics in Q1 2023 and held it in 10 quarters.
  • MCF Advisors's Procept Biorobotics position peaked at $25.7K in Q4 2024.
  • 242 funds tracked by Wall St. Rank held Procept Biorobotics as of Q3 2025.

Based on MCF Advisors's 13F filing for Q3 2025, filed 5 Nov 2025.